Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Joseph O Moore, et al.
Blood Advances|September 18, 2023
Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLLConstantine Tam, Javier Pinilla-Ibarz, Carolina G Castillo, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2011
Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER dataRami S Komrokji, Najla H Al Ali, M S Beg, et al.
Blood Advances|November 15, 2018
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemiaKamira Maharaj, John J Powers, Alex Achille, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2012
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparisonKristin M Phillips, Javier Pinilla-Ibarz, Eduardo Sotomayor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2011
Histone deacetylase inhibitor LAQ824 augments inflammatory responses in macrophages through transcriptional regulation of IL-10Hongwei Wang, Fengdong Cheng, Karrune Woan, et al.
Blood|November 5, 2005
Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease modelBarry J Kappel, Javier Pinilla-Ibarz, Adam A Kochman, et al.
American Journal of Hematology|April 23, 2013
Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromesAsmita Mishra, Maria Corrales-Yepez, Najla Al Ali, et al.
Pageof 16